System Transmission

Top Signal

100#1 JOB

Activity

2179Ripe

+920 today

System

Livenow

Terminal Asset View

stockNASDAQ

IMMX

$10.00-1.09%

Immix Biopharma Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

29Overripe

Live Analysis Active

Company Mission

Immix Biopharma Inc creates cancer treatments that specifically target tumors to reduce side effects. Doctors use these therapies for patients with hard-to-treat cancers to improve outcomes. The company makes money by selling these drugs and forming partnerships with larger pharmaceutical firms for development and distribution.

IMM

Industry Context

Immix Biopharma operates in the biotechnology sector, focusing on developing innovative treatments for cancer. This industry is highly competitive and research-intensive, with companies often relying on clinical trial successes to drive value.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

52Matrix

Market Momentum

70.1— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

-1.09%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing IMMX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 05:32 AM UTC

Develops targeted cancer therapies using advanced technology to treat patients with limited options, generating revenue through drug sales and partnerships.

No technical indicators available, but watch for price breaking above $10 as a potential signal of momentum if clinical trial results are positive, indicating investor confidence.

Volume spiked 3x at $8, indicating speculative interest because of upcoming data releases in the biotech sector. Monitor if volume stays above average to confirm sustained buying pressure.

Industry trend toward personalized medicine is driving strength, with price holding above $7 support, signaling resilience in a volatile market.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...